India restricts export of Covid-19 rapid antigen testing kits
New Delhi: The government on Monday imposed restrictions on export of COVID-19 rapid antigen testing kits amid several experts warning of a possible third wave of the coronavirus pandemic.
'The export of COVID-19 rapid antigen testing kits... has been put under restricted category, with immediate effect,' the directorate general of foreign trade (DGFT) said in a notification.
Exporters have to seek licence or permission from the DGFT to ship items under the restricted category. Such restrictions are aimed at increasing the domestic availability of the kits.
Read also: Pharma PLI scheme can generate Rs 1.96 lakh crore export over 6 years: Union Health Minister
Several experts have been warning of a possible third wave of the pandemic hitting the country in the near future.
The number of coronavirus cases in the country rose to 3,22,25,513 on Monday and the death toll climbed to 4,31,642, according to the Union health ministry data.
Read also: API exports stood at Rs 32,856 crore, imports at Rs 28,529 crore in FY21: Mansukh Mandaviya
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.